基于量子人工神经网络算法的hERG通道阻断器的高预测性3D-QSAR模型的推导
Taeho Kim1, Kee-Choo Chung1, Hwangseo Park1
1Department of Bioscience and Biotechnology, Sejong University, 209 Neungdong-ro, Kwangjin-gu, Seoul 05006, Republic of Korea.
Pharmaceuticals (Basel, Switzerland)
|November 25, 2023
概括
新的定量结构-活性关系 (QSAR) 模型预测hERG通道抑制,这是药物心脏毒性的关键因素. 这些模型使用3D静电潜力和高级对齐来有效地虚拟选候选药物.
科学领域:
- 计算化学计算化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 由于与潜在的致命心脏毒性相关,hERG通道是药物发现中的关键目标.
- 候选药物对hERG通道的非目标抑制是药物开发中的一个重大问题.
研究的目的:
- 开发对hERG通道抑制活性进行预测的定量结构-活性关系 (QSAR) 模型.
- 利用三维 (3D) 量子力学静电电位 (ESP) 作为预测心脏毒性的分子描述器.
主要方法:
- 开发了使用静电电位 (ESP) 作为分子描述器的3D-QSAR模型.
- 采用了一种新的3D结构对齐技术,以最大限度地提高量子力学交叉相关性,以适应多样化的分子结构.
- 将数据集分子根据分子重量划分为七个子集,以应对对齐挑战.
- 利用人工神经网络算法建立ESP描述符和实验hERG抑制活动之间的关系.
主要成果:
- 为所有七个分子子集实现了高度预测的3D-QSAR模型.
- 证明的平方相关系数超过0.79,表明模型性能强.
- 开发的模型有效地预测了结构多样化的分子中的hERG抑制活性.
结论:
- 开发的3D-QSAR模型为预测hERG通道抑制提供了一种简单而强大的方法.
- 这些模型有望成为有效的虚拟查工具,用于评估候选药物心脏毒性.
- 该研究提供了一种有价值的方法,用于在药物发现管道中早期识别潜在的心脏毒性化合物.
相关概念视频
Structure-Activity Relationships and Drug Design
729
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
729
Pharmacokinetic Models: Comparison and Selection Criterion
74
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
74
Pharmacokinetic Models: Overview
714
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
714
2D NMR: Heteronuclear Single-Quantum Correlation Spectroscopy (HSQC)
721
Heteronuclear single-quantum correlation spectroscopy (HSQC) is a 2D NMR technique that reveals one-bond correlations between hydrogen and a heteronucleus. The HSQC experiment is similar to the heteronuclear correlation experiment (HETCOR) but is more sensitive. In the HSQC spectrum, the proton chemical shift is plotted on the horizontal F2 axis, while the 13C chemical shift is plotted on the vertical F1 axis. The corresponding proton and 13C spectra are also shown. The HSQC contour plot does...
721
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
72
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
72
Three-Compartment Open Model
238
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
238


